Trial intelligence / Profile preview

Etanercept Versus Placebo in Ocular Manifestations of Behcet's Disease

IRCT138901292641N2Phase 4Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2010
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in Behçet's disease (BD) comparing Etanercept with Placebo (2 arms). Started Jun 2010; status: completed.

02

Drugs

etanercept
03

Conditions

Behçet's disease (BD)

Beyond the preview

Go deeper on IRCT138901292641N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138901292641N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call